Back to top
more

Penumbra (PEN)

(Delayed Data from NYSE)

$233.30 USD

233.30
525,994

+4.43 (1.94%)

Updated Nov 1, 2024 04:00 PM ET

After-Market: $233.26 -0.04 (-0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 32% (79 out of 250)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Here's Why Investors Should Hold Luminex (LMNX) Stock Now

Luminex (LMNX) gains from strength in the Aries platform. However, cutthroat competition in the life sciences industry is worrisome.

The Zacks Analyst Blog Highlights: Vanda Pharmaceuticals, Penumbra, G-III Apparel and General Finance

The Zacks Analyst Blog Highlights: Vanda Pharmaceuticals, Penumbra, G-III Apparel and General Finance

The Zacks Analyst Blog Highlights: Vanda Pharmaceuticals, Penumbra, G-III Apparel and General Finance

The Zacks Analyst Blog Highlights: Vanda Pharmaceuticals, Penumbra, G-III Apparel and General Finance

The Zacks Analyst Blog Highlights: Vanda Pharmaceuticals, Penumbra, G-III Apparel and General Finance

The Zacks Analyst Blog Highlights: Vanda Pharmaceuticals, Penumbra, G-III Apparel and General Finance

Ankita Gupta headshot

4 Stocks That Had Massive Earnings Surprises in 2018

Given the market volatility, let's take a look at four stocks that survived the onslaught and even surpassed market expectations.

Zacks.com featured highlights include: Abercrombie & Fitch, Pacira Pharmaceuticals, Penumbra, Sprint and Salesforce.com

Zacks.com featured highlights include: Abercrombie & Fitch, Pacira Pharmaceuticals, Penumbra, Sprint and Salesforce.com

OrthoPediatrics (KIDS) Catches Eye: Stock Jumps 10.3%

OrthoPediatrics (KIDS) saw a big move last session, as its shares jumped more than 10% on the day, amid huge volumes.

Sanghamitra Saha headshot

In Search of an Earnings Beat? Play These Top 5 Stocks

These top-ranked stocks may surpass bottom-line estimates in their next release.

Is Penumbra (PEN) Stock Outpacing Its Medical Peers This Year?

Is (PEN) Outperforming Other Medical Stocks This Year?

Zacks.com featured highlights include: Papa Murphy's, Penumbra, Tesla, Ameren and Arbor Realty

Zacks.com featured highlights include: Papa Murphy's, Penumbra, Tesla, Ameren and Arbor Realty

5 Low-Beta Stocks to Beat Market Volatility

We have developed a strategy to show that securities with lower volatility than the market can generate lucrative returns.

Is Penumbra (PEN) Outperforming Other Medical Stocks This Year?

Is (PEN) Outperforming Other Medical Stocks This Year?

DexCom (DXCM) Catches Eye: Stock Jumps 8.8%

DexCom (DXCM) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.

Penumbra (PEN) Surpasses Q3 Earnings and Revenue Estimates

Penumbra (PEN) delivered earnings and revenue surprises of 466.67% and 9.72%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

Penumbra (PEN) Q3 Earnings Preview: What to Watch Ahead of the Release

Penumbra (PEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Penumbra (PEN) Gains As Market Dips: What You Should Know

In the latest trading session, Penumbra (PEN) closed at $138.53, marking a +0.2% move from the previous day.

Is Penumbra (PEN) Stock Outpacing Its Medical Peers This Year?

Is (PEN) Outperforming Other Medical Stocks This Year?

Penumbra (PEN) Stock Moves -1.17%: What You Should Know

Penumbra (PEN) closed at $140.68 in the latest trading session, marking a -1.17% move from the prior day.

Penumbra (PEN) Stock Moves -1.9%: What You Should Know

Penumbra (PEN) closed at $131 in the latest trading session, marking a -1.9% move from the prior day.

Panel Of Zacks Experts headshot

Top Stock Picks for the Week of October 8th

Two Technology Companies With Different Focus.

Accelerate Diagnostics (AXDX) Surges: Stock Moves 6% Higher

Accelerate Diagnostics (AXDX) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.

Zacks Market Edge Highlights: Intuitive Surgical, BioTelemetry, Edwards Lifesciences, Penumbra and Vericel

Zacks Market Edge Highlights: Intuitive Surgical, BioTelemetry, Edwards Lifesciences, Penumbra and Vericel

    Tracey Ryniec headshot

    How to Invest in the Hot Medical Device Innovators

    Forget the biotechs. Medical device companies are innovating in amazing ways. Here's how to invest.

      Tandem Diabetes Care (TNDM) Catches Eye: Stock Jumps 7.4%

      Tandem Diabetes Care (TNDM) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

        Penumbra, Facebook, Softbank, Sony and Honda Motor highlighted as Zacks Bull and Bear of the Day

        Penumbra, Facebook, Softbank, Sony and Honda Motor highlighted as Zacks Bull and Bear of the Day